Cross Country Healthcare Inc. (NASDAQ:CCRN) was down 13.7% on Thursday . The company traded as low as $11.88 and last traded at $12.75, with a volume of 980,380 shares. The stock had previously closed at $14.77.

A number of equities research analysts recently weighed in on CCRN shares. TheStreet raised shares of Cross Country Healthcare from a “hold” rating to a “buy” rating in a research note on Wednesday, May 4th. Zacks Investment Research raised shares of Cross Country Healthcare from a “hold” rating to a “buy” rating and set a $16.00 price target for the company in a research note on Tuesday, July 5th. BMO Capital Markets reissued a “buy” rating and set a $16.00 price target on shares of Cross Country Healthcare in a research note on Friday. Finally, Cantor Fitzgerald reissued a “buy” rating on shares of Cross Country Healthcare in a research note on Sunday, July 17th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $17.75.

The stock has a market capitalization of $420.02 million and a PE ratio of 65.38. The company’s 50 day moving average is $14.56 and its 200 day moving average is $13.22.

Cross Country Healthcare (NASDAQ:CCRN) last announced its quarterly earnings data on Wednesday, August 3rd. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.13 by $0.03. The firm had revenue of $199.40 million for the quarter, compared to analyst estimates of $203.56 million. During the same quarter in the previous year, the company earned $0.10 earnings per share. The company’s quarterly revenue was up 3.5% on a year-over-year basis. On average, analysts forecast that Cross Country Healthcare Inc. will post $0.64 EPS for the current fiscal year.

In other news, SVP Deborah A. Dean sold 6,868 shares of the firm’s stock in a transaction that occurred on Monday, June 13th. The shares were sold at an average price of $14.34, for a total value of $98,487.12. Following the sale, the senior vice president now directly owns 46,214 shares in the company, valued at approximately $662,708.76. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Several large investors recently bought and sold shares of CCRN. I.G. Investment Management LTD. increased its stake in Cross Country Healthcare by 12.2% in the fourth quarter. I.G. Investment Management LTD. now owns 76,136 shares of the company’s stock valued at $1,248,000 after buying an additional 8,253 shares in the last quarter. Systematic Financial Management LP acquired a new stake in Cross Country Healthcare during the fourth quarter valued at approximately $1,651,000. Bank of Montreal Can increased its stake in Cross Country Healthcare by 19,623.6% in the fourth quarter. Bank of Montreal Can now owns 313,606 shares of the company’s stock valued at $5,139,000 after buying an additional 312,016 shares in the last quarter. Cornerstone Capital Management Holdings LLC. acquired a new stake in Cross Country Healthcare during the fourth quarter valued at approximately $1,062,000. Finally, California Public Employees Retirement System increased its stake in Cross Country Healthcare by 21.9% in the fourth quarter. California Public Employees Retirement System now owns 130,700 shares of the company’s stock valued at $2,142,000 after buying an additional 23,500 shares in the last quarter.

Cross Country Healthcare, Inc (CCRN) is engaged in providing healthcare recruiting, staffing and workforce solutions. The Company operates in three segments: Nurse and Allied Staffing, Physician Staffing and Other Human Capital Management Services. Its nurse and allied staffing segment is engaged in providing traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch-based local nurses and allied staffing through its Cross Country Staffing brand, MSN, AHG, Mediscan and DirectEd brands.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.